Log in to save to my catalogue

Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_251174

Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

Publication information

Publisher

Boston, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

Acromegaly is a chronic debilitating disorder resulting from excessive secretion of growth hormone and a resulting increase in the production of insulin-like growth factor I (IGF-I). It is usually caused by somatotroph adenomas of the pituitary gland. The goal of treatment is to reverse the effects of the hypersecretion of growth hormone and normal...

Alternative Titles

Full title

Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_251174

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_251174

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJM200004203421604